Share Article
SANTA MONICA, Calif., Nov. 4, 2015 (GLOBE NEWSWIRE) -- Kite Pharma, Inc. (Nasdaq:KITE) today announced that management will present at several upcoming investor conferences this month:
- Credit Suisse Healthcare Conference
Date: Tuesday, November 10, 2015 Time: 10:30am Mountain Time Location: Phoenix, AZ
- Stifel Nicolaus Healthcare Conference
Date: Tuesday, November 17, 2015Time: 11:45am Eastern TimeLocation: New York, NY
- Jefferies London Healthcare Conference
Date: Wednesday, November 18, 2015Time: 10:00am Greenwich Mean TimeLocation: London, UK
- Goldman Sachs US Emerging/SMID Cap Growth Conference 2015
Date: Thursday, November 19, 2015Time: 3:10pm Eastern TimeLocation: New York, NY
Kite's corporate overview to be presented at each of the conferences will be available through the Calendar of Events section of Kite's website at ir.kitepharma.com. The presentations from the Jefferies London Healthcare Conference and the Goldman Sachs US Emerging/SMID Cap Growth Conference will be webcasted and will be available along with the corporate overview to be presented at each of the November conferences through the Calendar of Events section of Kite's website at ir.kitepharma.com.
About Kite Pharma, Inc.
Kite Pharma, Inc. is a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a primary focus on engineered autologous cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors. Kite is based in Santa Monica, CA. For more information on Kite Pharma, please visit www.kitepharma.com. Sign up to follow @KitePharma on Twitter at www.twitter.com/kitepharma.
CONTACT: Kite Pharma:
Cynthia M. Butitta, Chief Financial Officer
and Chief Operating Officer
310-824-9999
For Media: Justin Jackson
For Investor Inquiries: Lisa Burns
Burns McClellan
212-213-0006
jjackson@burnsmc.com
lburns@burnsmc.com
Other News
Some of the content on this page is not intended for users outside the U.S.